234 related articles for article (PubMed ID: 8539632)
1. Adjuvant systemic therapy for breast cancer.
Harris DT
Semin Oncol; 1995 Dec; 22(6):553-70. PubMed ID: 8539632
[No Abstract] [Full Text] [Related]
2. [Adjuvant therapy in breast cancer].
Semiglazov VF
Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
[No Abstract] [Full Text] [Related]
3. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Kunkler I
J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
[No Abstract] [Full Text] [Related]
4. Still waiting after 110 years: the optimal use of ovarian ablation as adjuvant therapy for breast cancer.
Wolff AC; Davidson NE
J Clin Oncol; 2006 Nov; 24(31):4949-51. PubMed ID: 17075110
[No Abstract] [Full Text] [Related]
5. Current status of adjuvant endocrine therapy for resectable breast cancer.
Pritchard KI
Semin Oncol; 1987 Mar; 14(1):23-33. PubMed ID: 3547666
[No Abstract] [Full Text] [Related]
6. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
[TBL] [Abstract][Full Text] [Related]
7. [Adjuvant therapy of breast cancer].
Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
[No Abstract] [Full Text] [Related]
8. More evidence that locoregional radiation therapy improves survival: what should we do?
Whelan T; Levine M
J Natl Cancer Inst; 2005 Jan; 97(2):82-4. PubMed ID: 15657332
[No Abstract] [Full Text] [Related]
9. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant systemic therapy of breast cancer.
Lippman ME
Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744
[No Abstract] [Full Text] [Related]
11. Primary chemotherapy in surgically resectable breast cancer: the experience of the Milan Cancer Institute.
Valagussa P; Bonadonna G
Zentralbl Gynakol; 1996; 118(10):571. PubMed ID: 8912477
[No Abstract] [Full Text] [Related]
12. Adjuvant therapy for breast cancer: we are solving the puzzle, but pieces are still missing.
Pritchard KI
J Natl Cancer Inst; 2007 Apr; 99(7):494-5. PubMed ID: 17405988
[No Abstract] [Full Text] [Related]
13. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
Cancer Control; 2001; 8(1):55. PubMed ID: 11176036
[No Abstract] [Full Text] [Related]
14. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
[TBL] [Abstract][Full Text] [Related]
15. [Benefits of adjuvant chemotherapy for breast cancer].
Motomura K; Noguchi S; Inaji H; Koyama H
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1239-44. PubMed ID: 9279342
[TBL] [Abstract][Full Text] [Related]
16. [Taxanes in neojuvant radio-, chemoradio- and chemotherapy for breast cancer].
Bozhok AA; Semiglazov VF; Kletzel' AE; Arzumanov AS; Mel'nikova OA; Paltuev RM; Ivanova OA; Semiglazov VV
Vopr Onkol; 2006; 52(1):7-14. PubMed ID: 16715697
[No Abstract] [Full Text] [Related]
17. [Recent advance in adjuvant therapy for breast cancer].
Shimizu C; Watanabe T
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
[TBL] [Abstract][Full Text] [Related]
18. [Breast cancer: the majority of women need adjuvant therapy. Even in the absence of lymphatic metastases adjuvant therapy can be useful].
Schalhorn B
Fortschr Med; 1999 Apr; 117(12):35. PubMed ID: 10361370
[No Abstract] [Full Text] [Related]
19. Current status of adjuvant chemotherapy for breast cancer.
Bonadonna G; Valagussa P
Semin Oncol; 1987 Mar; 14(1):8-22. PubMed ID: 3547668
[No Abstract] [Full Text] [Related]
20. [Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology].
Bontenbal M; Nortier JW; Beex LV; Bakker P; Hupperets PS; Nooij MA; van Veelen H; Vreugdenhil G; Richel DJ; Blijham GH
Ned Tijdschr Geneeskd; 2000 May; 144(21):984-9. PubMed ID: 10858788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
